Skip to content

Frequent, far infra-red (FIR) therapy for newly formed arterio-venous fistulas in dialysis and pre-dialysis patients

Frequent, far infra-red (FIR) therapy for newly formed arterio-venous fistulas in dialysis and pre-dialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN07415424
Enrollment
72
Registered
2013-05-03
Start date
2013-05-01
Completion date
Unknown
Last updated
2017-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Topic: Renal and Urogenital

Interventions

Current interventions as of 15/09/2014: Pre-dialysis or dialysis patients awaiting AV fistula formation and randomised on a 1:1 basis between treatment and control groups. Far infrared (FIR) therapy,

Sponsors

Newcastle upon Tyne Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Current inclusion criteria as of 15/09/2014: 1. Pre-dialysis or dialysis patients undergoing formation of a brachial arterio-venous fistula 2. Ability to provide informed consent 3. Male and female, age >= 18 years Previous inclusion criteria: 1. Pre-dialysis patients undergoing formation of a brachial arterio-venous fistula 2. Ability to provide informed consent 3. Male and female, age >= 18 years

Exclusion criteria

Exclusion criteria: 1. Impaired conscious level at the time of 1st FIR therapy 2. Impaired peripheral sensation

Design outcomes

Primary

MeasureTime frame
Access flow at 6 weeks measured by ultrasound

Secondary

MeasureTime frame
Access flow at 12 weeks after AV fistula formation measured by ultrasound

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026